28
Participants
Start Date
April 6, 2017
Primary Completion Date
December 5, 2019
Study Completion Date
March 30, 2020
Levonorgestrel
Increased dose levonorgestrel implant plus efavirenz-based antiretroviral therapy.
Efavirenz
Participants will receive efavirenz-based ART as part of standard of care
Infectious Diseases Institute, Kampala
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Infectious Diseases Institute, Uganda
OTHER
University of Liverpool
OTHER
Northwestern University Feinberg School of Medicine
OTHER
University of Nebraska
OTHER